208 related articles for article (PubMed ID: 10878336)
1. Langerhans cells that have matured in vivo in the absence of T cells are fully capable of inducing a helper CD4 as well as a cytotoxic CD8 response.
De Creus A; Van Beneden K; Taghon T; Stolz F; Debacker V; Plum J; Leclercq G
J Immunol; 2000 Jul; 165(2):645-53. PubMed ID: 10878336
[TBL] [Abstract][Full Text] [Related]
2. Epidermal and dermal dendritic cells display differential activation and migratory behavior while sharing the ability to stimulate CD4+ T cell proliferation in vivo.
Shklovskaya E; Roediger B; Fazekas de St Groth B
J Immunol; 2008 Jul; 181(1):418-30. PubMed ID: 18566408
[TBL] [Abstract][Full Text] [Related]
3. Dicer-dependent microRNAs control maturation, function, and maintenance of Langerhans cells in vivo.
Kuipers H; Schnorfeil FM; Fehling HJ; Bartels H; Brocker T
J Immunol; 2010 Jul; 185(1):400-9. PubMed ID: 20530258
[TBL] [Abstract][Full Text] [Related]
4. Langerhans cells derived from genetically modified human CD34+ hemopoietic progenitors are more potent than peptide-pulsed Langerhans cells for inducing antigen-specific CD8+ cytolytic T lymphocyte responses.
Yuan J; Latouche JB; Reagan JL; Heller G; Riviere I; Sadelain M; Young JW
J Immunol; 2005 Jan; 174(2):758-66. PubMed ID: 15634896
[TBL] [Abstract][Full Text] [Related]
5. The mandatory role of IL-10-producing and OX40 ligand-expressing mature Langerhans cells in local UVB-induced immunosuppression.
Yoshiki R; Kabashima K; Sakabe J; Sugita K; Bito T; Nakamura M; Malissen B; Tokura Y
J Immunol; 2010 May; 184(10):5670-7. PubMed ID: 20400709
[TBL] [Abstract][Full Text] [Related]
6. Systemic treatment with anti-CD40 antibody stimulates Langerhans cell migration from the skin.
Jolles S; Christensen J; Holman M; Klaus GB; Ager A
Clin Exp Immunol; 2002 Sep; 129(3):519-26. PubMed ID: 12197894
[TBL] [Abstract][Full Text] [Related]
7. Freshly isolated Langerhans cells negatively regulate naïve T cell activation in response to peptide antigen through cell-to-cell contact.
Imai Y; Hayashi N; Yasuda K; Tsutsui H; Mizutani H; Nakanishi K
J Dermatol Sci; 2008 Jul; 51(1):19-29. PubMed ID: 18367382
[TBL] [Abstract][Full Text] [Related]
8. Oral administration of hapten inhibits in vivo induction of specific cytotoxic CD8+ T cells mediating tissue inflammation: a role for regulatory CD4+ T cells.
Desvignes C; Etchart N; Kehren J; Akiba I; Nicolas JF; Kaiserlian D
J Immunol; 2000 Mar; 164(5):2515-22. PubMed ID: 10679089
[TBL] [Abstract][Full Text] [Related]
9. Alpha 6 integrins are required for Langerhans cell migration from the epidermis.
Price AA; Cumberbatch M; Kimber I; Ager A
J Exp Med; 1997 Nov; 186(10):1725-35. PubMed ID: 9362532
[TBL] [Abstract][Full Text] [Related]
10. Innate immunity mediated by epidermal keratinocytes promotes acquired immunity involving Langerhans cells and T cells in the skin.
Sugita K; Kabashima K; Atarashi K; Shimauchi T; Kobayashi M; Tokura Y
Clin Exp Immunol; 2007 Jan; 147(1):176-83. PubMed ID: 17177977
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor gamma inhibits the migration of dendritic cells: consequences for the immune response.
Angeli V; Hammad H; Staels B; Capron M; Lambrecht BN; Trottein F
J Immunol; 2003 May; 170(10):5295-301. PubMed ID: 12734379
[TBL] [Abstract][Full Text] [Related]
12. Langerhans-type dendritic cells genetically modified to express full-length antigen optimally stimulate CTLs in a CD4-dependent manner.
Yuan J; Latouche JB; Hodges J; Houghton AN; Heller G; Sadelain M; Riviere I; Young JW
J Immunol; 2006 Feb; 176(4):2357-65. PubMed ID: 16455993
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells.
Geissmann F; Revy P; Regnault A; Lepelletier Y; Dy M; Brousse N; Amigorena S; Hermine O; Durandy A
J Immunol; 1999 Apr; 162(8):4567-75. PubMed ID: 10201996
[TBL] [Abstract][Full Text] [Related]
14. Dermal dendritic cells, and not Langerhans cells, play an essential role in inducing an immune response.
Fukunaga A; Khaskhely NM; Sreevidya CS; Byrne SN; Ullrich SE
J Immunol; 2008 Mar; 180(5):3057-64. PubMed ID: 18292528
[TBL] [Abstract][Full Text] [Related]
15. TGF-beta is required to maintain the pool of immature Langerhans cells in the epidermis.
Kel JM; Girard-Madoux MJ; Reizis B; Clausen BE
J Immunol; 2010 Sep; 185(6):3248-55. PubMed ID: 20713882
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of functional T cell priming and contact hypersensitivity responses by treatment with anti-secondary lymphoid chemokine antibody during hapten sensitization.
Engeman TM; Gorbachev AV; Gladue RP; Heeger PS; Fairchild RL
J Immunol; 2000 May; 164(10):5207-14. PubMed ID: 10799880
[TBL] [Abstract][Full Text] [Related]
17. Human langerhans cells are more efficient than CD14(-)CD1c(+) dermal dendritic cells at priming naive CD4(+) T cells.
Furio L; Briotet I; Journeaux A; Billard H; Péguet-Navarro J
J Invest Dermatol; 2010 May; 130(5):1345-54. PubMed ID: 20107482
[TBL] [Abstract][Full Text] [Related]
18. TIM-4 is differentially expressed in the distinct subsets of dendritic cells in skin and skin-draining lymph nodes and controls skin Langerhans cell homeostasis.
Zhang X; Liu Q; Wang J; Li G; Weiland M; Yu FS; Mi QS; Gu J; Zhou L
Oncotarget; 2016 Jun; 7(25):37498-37512. PubMed ID: 27224924
[TBL] [Abstract][Full Text] [Related]
19. IL-1 alpha, but not IL-1 beta, is required for contact-allergen-specific T cell activation during the sensitization phase in contact hypersensitivity.
Nakae S; Naruse-Nakajima C; Sudo K; Horai R; Asano M; Iwakura Y
Int Immunol; 2001 Dec; 13(12):1471-8. PubMed ID: 11717188
[TBL] [Abstract][Full Text] [Related]
20. Src homology 2 domain-containing protein tyrosine phosphatase substrate 1 regulates the migration of Langerhans cells from the epidermis to draining lymph nodes.
Fukunaga A; Nagai H; Noguchi T; Okazawa H; Matozaki T; Yu X; Lagenaur CF; Honma N; Ichihashi M; Kasuga M; Nishigori C; Horikawa T
J Immunol; 2004 Apr; 172(7):4091-9. PubMed ID: 15034021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
